171 related articles for article (PubMed ID: 30846792)
21. Tumor biology and pre-transplant locoregional treatments determine outcomes in patients with T3 hepatocellular carcinoma undergoing liver transplantation.
Kim PT; Onaca N; Chinnakotla S; Davis GL; Jennings LW; McKenna GJ; Ruiz RM; Levy MF; Goldstein R; Klintmalm GB
Clin Transplant; 2013; 27(2):311-8. PubMed ID: 23351129
[TBL] [Abstract][Full Text] [Related]
22. Milan criteria are useful predictors for favorable outcomes in hepatocellular carcinoma patients undergoing liver transplantation after transarterial chemoembolization.
Kim DY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC; Shin SW; Choo SW; Do YS; Rhee JC
World J Gastroenterol; 2006 Nov; 12(43):6992-7. PubMed ID: 17109521
[TBL] [Abstract][Full Text] [Related]
23. Are There Upper Limits in Tumor Burden for Down-Staging of Hepatocellular Carcinoma to Liver Transplant? Analysis of the All-Comers Protocol.
Sinha J; Mehta N; Dodge JL; Poltavskiy E; Roberts J; Yao F
Hepatology; 2019 Oct; 70(4):1185-1196. PubMed ID: 30779440
[TBL] [Abstract][Full Text] [Related]
24. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis.
Kulik L; Heimbach JK; Zaiem F; Almasri J; Prokop LJ; Wang Z; Murad MH; Mohammed K
Hepatology; 2018 Jan; 67(1):381-400. PubMed ID: 28859222
[TBL] [Abstract][Full Text] [Related]
25. Survival benefit of transplantation for recurrence of hepatocellular carcinoma after liver resection.
Tuci F; Vitale A; D'Amico F; Gringeri E; Neri D; Zanus G; Bassi D; Polacco M; Boetto R; Lodo E; Germani G; Burra P; Angeli P; Cillo U
Transplant Proc; 2014 Sep; 46(7):2287-9. PubMed ID: 25242770
[TBL] [Abstract][Full Text] [Related]
26. Complete pathologic response to pretransplant locoregional therapy for hepatocellular carcinoma defines cancer cure after liver transplantation: analysis of 501 consecutively treated patients.
Agopian VG; Morshedi MM; McWilliams J; Harlander-Locke MP; Markovic D; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Hiatt JR; Busuttil RW
Ann Surg; 2015 Sep; 262(3):536-45; discussion 543-5. PubMed ID: 26258323
[TBL] [Abstract][Full Text] [Related]
27. Extended postinterventional tumor necrosis-implication for outcome in liver transplant patients with advanced HCC.
Kornberg A; Witt U; Matevossian E; Küpper B; Assfalg V; Drzezga A; Hüser N; Wildgruber M; Friess H
PLoS One; 2013; 8(1):e53960. PubMed ID: 23349774
[TBL] [Abstract][Full Text] [Related]
28. Section 3. Current status of downstaging of hepatocellular carcinoma before liver transplantation.
Sharr WW; Chan SC; Lo CM
Transplantation; 2014 Apr; 97 Suppl 8():S10-7. PubMed ID: 24849822
[TBL] [Abstract][Full Text] [Related]
29. Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria.
Yao FY; Mehta N; Flemming J; Dodge J; Hameed B; Fix O; Hirose R; Fidelman N; Kerlan RK; Roberts JP
Hepatology; 2015 Jun; 61(6):1968-77. PubMed ID: 25689978
[TBL] [Abstract][Full Text] [Related]
30. Significance of tumor necrosis for outcome of patients with hepatocellular carcinoma receiving locoregional therapy prior to liver transplantation.
Chan KM; Yu MC; Chou HS; Wu TJ; Lee CF; Lee WC
Ann Surg Oncol; 2011 Sep; 18(9):2638-46. PubMed ID: 21584831
[TBL] [Abstract][Full Text] [Related]
31. Number and tumor size are not sufficient criteria to select patients for liver transplantation for hepatocellular carcinoma.
Piardi T; Gheza F; Ellero B; Woehl-Jaegle ML; Ntourakis D; Cantu M; Marzano E; Audet M; Wolf P; Pessaux P
Ann Surg Oncol; 2012 Jun; 19(6):2020-6. PubMed ID: 22179632
[TBL] [Abstract][Full Text] [Related]
32. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
[TBL] [Abstract][Full Text] [Related]
33. Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate.
Cescon M; Cucchetti A; Ravaioli M; Pinna AD
J Hepatol; 2013 Mar; 58(3):609-18. PubMed ID: 23041304
[TBL] [Abstract][Full Text] [Related]
34. Excellent Outcomes of Liver Transplantation Following Down-Staging of Hepatocellular Carcinoma to Within Milan Criteria: A Multicenter Study.
Mehta N; Guy J; Frenette CT; Dodge JL; Osorio RW; Minteer WB; Roberts JP; Yao FY
Clin Gastroenterol Hepatol; 2018 Jun; 16(6):955-964. PubMed ID: 29175528
[TBL] [Abstract][Full Text] [Related]
35. Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10-year intention-to-treat analysis.
Lee MW; Raman SS; Asvadi NH; Siripongsakun S; Hicks RM; Chen J; Worakitsitisatorn A; McWilliams J; Tong MJ; Finn RS; Agopian VG; Busuttil RW; Lu DSK
Hepatology; 2017 Jun; 65(6):1979-1990. PubMed ID: 28170115
[TBL] [Abstract][Full Text] [Related]
36. Downstaging therapy followed by liver transplantation for hepatocellular carcinoma beyond Milan criteria.
Kim Y; Stahl CC; Makramalla A; Olowokure OO; Ristagno RL; Dhar VK; Schoech MR; Chadalavada S; Latif T; Kharofa J; Bari K; Shah SA
Surgery; 2017 Dec; 162(6):1250-1258. PubMed ID: 29033224
[TBL] [Abstract][Full Text] [Related]
37. Benefit of downsizing hepatocellular carcinoma in a liver transplant population.
Jang JW; You CR; Kim CW; Bae SH; Yoon SK; Yoo YK; Kim DG; Choi JY
Aliment Pharmacol Ther; 2010 Feb; 31(3):415-23. PubMed ID: 19821808
[TBL] [Abstract][Full Text] [Related]
38. The clinical behavior of transplantable recurrent hepatocellular carcinoma after curative resection: implications for salvage liver transplantation.
Lee HS; Choi GH; Joo DJ; Kim MS; Choi JS; Kim SI
Ann Surg Oncol; 2014 Aug; 21(8):2717-24. PubMed ID: 24916744
[TBL] [Abstract][Full Text] [Related]
39. Downstaging hepatocellular carcinoma: A systematic review and pooled analysis.
Parikh ND; Waljee AK; Singal AG
Liver Transpl; 2015 Sep; 21(9):1142-52. PubMed ID: 25981135
[TBL] [Abstract][Full Text] [Related]
40. Impact of transarterial therapy in hepatitis C-related hepatocellular carcinoma on long-term outcomes after liver transplantation.
Cabrera R; Dhanasekaran R; Caridi J; Clark V; Morelli G; Soldevila-Pico C; Magglioca J; Nelson D; Firpi RJ
Am J Clin Oncol; 2012 Aug; 35(4):345-50. PubMed ID: 21552101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
